Abstract

To analyze intraoperative data and possible differences in clinical evolution during postoperative hospital phase for aortic valve replacement surgery using different types of prosthesis. Analysis of 60 patients divided into three groups. Valve replacement with bioprosthesis (20), mechanical prosthesis (20) and homologous valve (20). The mean age was 51.1, 60% were male and 40% female patients; 86.7 % were in NYHA II or III; 63.3% presented arterial hypertension and 18.3% had diabetes. Aetiology of valve disease was degenerative for 39%, rheumatic for 36% and endocarditis for 15%. The hospital mortality was 5%; there were no differences in the incidence of septic or cardiogenic shock, acute renal failure, rhythms disorders during surgery or intensive care, neither for total time in intensive care and mechanical ventilation. However, there was statistical differences as regards the cardiopulmonary bypass total time (P=0.02) and the aortic clamping time (P<0.0001) unfavorable to homograft valve group. The ward admission time was greater for mechanical valve group (P=0.05) as well as for total admission time, but without statistical significance. It was observed that patients with preoperative hematocrit smaller than 38.1% used 2.73 units of blood components, and with postoperative hematocrit smaller than 32% used 1,79 units of blood components. Echocardiography control showed minimal evolutional differences. The use of different types of prosthesis for this study does not cause differences in the results of postoperative hospital phase. The use of homograft valve is a feasible option with good clinical applicability.

Highlights

  • In Brazil, the biological prosthesis has been the most used replacement valve

  • The use of homograft valve is a feasible option with good clinical applicability

  • The mean age of this group was only statistically significant when compared to the group with biological prosthesis replacements (P=0.03), and didn’t interfere with the overall analysis of the sample

Read more

Summary

Introduction

In Brazil, the biological prosthesis has been the most used replacement valve We see this preference for countless reasons, such as patient’s socioeconomic condition, and cases when there is no need for life-long anticoagulation. These prostheses have evolved in our country, beginning with the biological tissues of dura mater, as published by Puig et al [1,2], and shifting to bovine pericardium and porcine valves made into rings [3,4]. The limitation for their use is directly related to their durability and calcification issues, as well as a need for reoperation with increased surgical risk [4,5] They are often recommended, especially in the elderly and those unable to undergo an anticoagulation regime

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call